[tds_menu_login inline="yes" guest_tdicon="td-icon-profile" logout_tdicon="td-icon-log-out" tdc_css="eyJwaG9uZSI6eyJtYXJnaW4tcmlnaHQiOiIyMCIsIm1hcmdpbi1ib3R0b20iOiIwIiwibWFyZ2luLWxlZnQiOiI2IiwiZGlzcGxheSI6IiJ9LCJwaG9uZV9tYXhfd2lkdGgiOjc2N30=" toggle_hide="eyJwaG9uZSI6InllcyJ9" ia_space="eyJwaG9uZSI6IjAifQ==" icon_size="eyJhbGwiOjI0LCJwaG9uZSI6IjIwIn0=" avatar_size="eyJwaG9uZSI6IjIwIn0=" show_menu="yes" menu_offset_top="eyJwaG9uZSI6IjE4In0=" menu_offset_horiz="eyJhbGwiOjgsInBob25lIjoiLTMifQ==" menu_width="eyJwaG9uZSI6IjE4MCJ9" menu_horiz_align="eyJhbGwiOiJjb250ZW50LWhvcml6LWxlZnQiLCJwaG9uZSI6ImNvbnRlbnQtaG9yaXotcmlnaHQifQ==" menu_uh_padd="eyJwaG9uZSI6IjEwcHggMTVweCA4cHgifQ==" menu_gh_padd="eyJwaG9uZSI6IjEwcHggMTVweCA4cHgifQ==" menu_ul_padd="eyJwaG9uZSI6IjhweCAxNXB4In0=" menu_ul_space="eyJwaG9uZSI6IjYifQ==" menu_ulo_padd="eyJwaG9uZSI6IjhweCAxNXB4IDEwcHgifQ==" menu_gc_padd="eyJwaG9uZSI6IjhweCAxNXB4IDEwcHgifQ==" menu_bg="var(--news-hub-black)" menu_shadow_shadow_size="eyJwaG9uZSI6IjAifQ==" menu_arrow_color="rgba(0,0,0,0)" menu_uh_color="var(--news-hub-light-grey)" menu_uh_border_color="var(--news-hub-dark-grey)" menu_ul_link_color="var(--news-hub-white)" menu_ul_link_color_h="var(--news-hub-accent-hover)" menu_ul_sep_color="var(--news-hub-dark-grey)" menu_uf_txt_color="var(--news-hub-white)" menu_uf_txt_color_h="var(--news-hub-accent-hover)" menu_uf_border_color="var(--news-hub-dark-grey)" f_uh_font_size="eyJwaG9uZSI6IjEyIn0=" f_uh_font_line_height="eyJwaG9uZSI6IjEuMyJ9" f_uh_font_family="eyJwaG9uZSI6IjMyNSJ9" f_links_font_size="eyJwaG9uZSI6IjEyIn0=" f_links_font_line_height="eyJwaG9uZSI6IjEuMyJ9" f_links_font_family="eyJwaG9uZSI6IjMyNSJ9" f_uf_font_size="eyJwaG9uZSI6IjEyIn0=" f_uf_font_line_height="eyJwaG9uZSI6IjEuMyJ9" f_uf_font_family="eyJwaG9uZSI6IjMyNSJ9" f_gh_font_family="eyJwaG9uZSI6IjMyNSJ9" f_gh_font_size="eyJwaG9uZSI6IjEyIn0=" f_gh_font_line_height="eyJwaG9uZSI6IjEuMyJ9" f_btn1_font_family="eyJwaG9uZSI6IjMyNSJ9" f_btn1_font_weight="eyJwaG9uZSI6IjcwMCJ9" f_btn1_font_transform="eyJwaG9uZSI6InVwcGVyY2FzZSJ9" f_btn2_font_weight="eyJwaG9uZSI6IjcwMCJ9" f_btn2_font_transform="eyJwaG9uZSI6InVwcGVyY2FzZSJ9" f_btn2_font_family="eyJwaG9uZSI6IjMyNSJ9"]
-8.5 C
New York
[tds_menu_login guest_tdicon="td-icon-profile" logout_tdicon="td-icon-log-out" tdc_css="eyJhbGwiOnsibWFyZ2luLWJvdHRvbSI6IjAiLCJkaXNwbGF5IjoiIn19" toggle_txt_color="var(--news-hub-white)" menu_offset_top="eyJhbGwiOiIxOSIsImxhbmRzY2FwZSI6IjE3IiwicG9ydHJhaXQiOiIxNSJ9" menu_offset_horiz="eyJhbGwiOi02LCJsYW5kc2NhcGUiOiItMyIsInBvcnRyYWl0IjoiLTIifQ==" menu_horiz_align="content-horiz-right" menu_bg="var(--news-hub-black)" menu_uh_color="var(--news-hub-light-grey)" menu_uh_border_color="var(--news-hub-dark-grey)" menu_ul_link_color="#ffffff" menu_ul_link_color_h="var(--news-hub-accent-hover)" menu_ul_sep_color="var(--news-hub-dark-grey)" menu_uf_txt_color="var(--news-hub-white)" menu_uf_txt_color_h="var(--news-hub-accent-hover)" menu_uf_border_color="var(--news-hub-dark-grey)" f_uh_font_family="325" f_uh_font_line_height="1.3" f_links_font_family="325" f_links_font_line_height="1.3" f_uf_font_line_height="1.3" f_uf_font_family="325" menu_uh_padd="eyJhbGwiOiIyMHB4IDI1cHggMThweCIsImxhbmRzY2FwZSI6IjE1cHggMjBweCAxM3B4IiwicG9ydHJhaXQiOiIxMHB4IDE1cHggOHB4In0=" menu_ul_padd="eyJhbGwiOiIxOHB4IDI1cHgiLCJsYW5kc2NhcGUiOiIxNnB4IDIwcHgiLCJwb3J0cmFpdCI6IjhweCAxNXB4In0=" menu_ul_space="eyJhbGwiOiIxMCIsImxhbmRzY2FwZSI6IjgiLCJwb3J0cmFpdCI6IjYifQ==" menu_ulo_padd="eyJhbGwiOiIxOHB4IDI1cHggMjBweCIsImxhbmRzY2FwZSI6IjEzcHggMjBweCAxNXB4IiwicG9ydHJhaXQiOiI4cHggMTVweCAxMHB4In0=" menu_shadow_shadow_size="0" menu_arrow_color="rgba(255,255,255,0)" menu_width="eyJhbGwiOiIyMjAiLCJwb3J0cmFpdCI6IjE4MCJ9" show_version="" menu_gh_padd="eyJhbGwiOiIyMHB4IDI1cHggMThweCIsImxhbmRzY2FwZSI6IjE1cHggMjBweCAxM3B4IiwicG9ydHJhaXQiOiIxMHB4IDE1cHggOHB4In0=" menu_gc_padd="eyJhbGwiOiIxOHB4IDI1cHggMjBweCIsImxhbmRzY2FwZSI6IjEzcHggMjBweCAxNXB4IiwicG9ydHJhaXQiOiI4cHggMTVweCAxMHB4In0=" menu_gh_color="var(--news-hub-light-grey)" menu_gh_border_color="var(--news-hub-dark-grey)" f_gh_font_family="325" menu_gc_btn1_bg_color="var(--news-hub-accent)" menu_gc_btn1_bg_color_h="var(--news-hub-accent-hover)" menu_gc_btn2_color="var(--news-hub-accent)" menu_gc_btn2_color_h="var(--news-hub-accent-hover)" f_btn1_font_family="325" f_btn1_font_transform="uppercase" f_btn2_font_family="325" f_btn2_font_transform="uppercase" f_btn1_font_weight="700" f_btn2_font_weight="700" show_menu="yes" f_uf_font_size="eyJsYW5kc2NhcGUiOiIxMiIsInBvcnRyYWl0IjoiMTIifQ==" icon_color="var(--news-hub-white)" icon_size="eyJhbGwiOjIyLCJsYW5kc2NhcGUiOiIyMCIsInBvcnRyYWl0IjoiMTgifQ==" avatar_size="eyJhbGwiOiIyMiIsImxhbmRzY2FwZSI6IjIwIiwicG9ydHJhaXQiOiIxOCJ9" ia_space="eyJhbGwiOiIxMCIsImxhbmRzY2FwZSI6IjgiLCJwb3J0cmFpdCI6IjYifQ==" f_toggle_font_family="325" f_toggle_font_size="eyJhbGwiOiIxNCIsImxhbmRzY2FwZSI6IjEzIiwicG9ydHJhaXQiOiIxMiJ9" logout_size="eyJhbGwiOjE0LCJsYW5kc2NhcGUiOiIxMyJ9" f_uh_font_size="eyJsYW5kc2NhcGUiOiIxMyIsInBvcnRyYWl0IjoiMTIifQ==" f_links_font_size="eyJsYW5kc2NhcGUiOiIxMyIsInBvcnRyYWl0IjoiMTIifQ==" f_gh_font_size="eyJsYW5kc2NhcGUiOiIxMyIsInBvcnRyYWl0IjoiMTIifQ=="]
News

Apple Might Launch Its Own Smart Home Camera As It Focuses On Providing A More Integrated Product Experience For Its Users

Wccftech.com - 0
Apple is increasingly focusing on building its own devices and expanding its ecosystem by taking steps towards a more native experience for users and relying less on third-party accessories. While the Cupertino-based tech giant's HomePod and AppleTV have left quite the mark in the smart home category, it generally relies more on outsourcing cameras and other hardware for smart homes. Now, a new report suggests that the company intends to create a fully integrated experience by developing its own smart home accessories. Gurman hints about Apple working on making smart home products like security cameras for a more integrated experience […]
Deals

Best of Black Friday 2024 – power stations and bundles: Anker SOLIX, Bluetti, EcoFlow, Jackery

9to5Toys.com - 0
We’re continuing our Best of Black Friday posts today with a look at the best current deals on power stations and their respective bundle options. Folks across the country and beyond have been steadily investing more and more in the industry for a vari...
gaming

World Of Warcraft Is Finally Getting Player Homes After 20 Years

Kotaku.com - 0
Blizzard has announced that two decades after its release, World of Warcraft is finally going to let players build a home and live in it. The feature has long been requested by WoW players and now it’s finally coming in the game’s next expansion.Read m...
News

ArenaNet To Release ‘Godspawn’ Update for Guild Wars 2: Janthir Wilds on November 19, Featuring New 50-Player Titan Battle and More

Wccftech.com - 0
Guild Wars 2: Janthir Wilds will receive the Godspawn update, adding a new 50-player boss battle, a new 10-player raid, and a legendary spear. Guild Wars 2: Janthir Wilds is getting the first major update "Godspawn" on November 19th, expanding the story with new story chapters The MMORPG Guild Wars 2 by ArenaNet is receiving its first major update for the Janthir Wilds expansion soon. It's the first of three major updates, and it'll land on November 19. The update will add new content to the game for the players. The Janthir Wilds expansion DLC was released in August this year, […]

Score a 2TB 7,400MB/s Nextorage heatsink SSD compatible with PS5 at $110 low

Classic RTS Games Warcraft and Warcraft 2 Fully Remastered And Out Now

Native Union Classic Apple Watch Strap with soft nubuck leather lining now $20 (Reg. up to $60)

Amazon has ENGWE’s E26 dual suspension all-terrain e-bike hitting a new $849 low (Reg. $1,399)

Hello! Score 50% off Sam’s Club memberships just in time for the holidays at $25 (Reg. $50)

Dragon Age: The Veilguard’s Hardest Choice Has Fans Scouring For A Way Out

Spigen’s Titanium Keychain Multi-tool with knife, bottle opener, and carabiner now $34 (50% off)

NVIDIA’s DLSS 3.8.10 Package Reduces Preset Modes To Just Two Profiles, Drastically Reducing DLL File Size

Xbox Boss Says No ‘Red Line’ With Exclusives, Including Even Halo

PlayStation Store and Xbox gift cards now on sale from $9 ahead of upcoming Black Friday sales

Apple Will Launch A New ‘Command Center’ Home Device In March With Apple Intelligence Integration, As It Steps Into The Home Industry

Heybike’s Cityrun commuter e-bike carries you up to 55 miles of travel on a four-hour charge at $999 low (Save $600), more

Get two fully adjustable foldable smartphone holders on rotating metal bases at just $8 Prime shipped ($4 ea.)

What did the snowball Earth look like?

PlayStation Plus Brings Back Grand Theft Auto V And A Bunch Of Other Big Games

How Valve made Half-Life 2 and set a new standard for future games

Apple’s MetalFX Upscaling Comparison At 1080p Running Resident Evil 4 Remake Shows Reduced Image Quality, But Framerate Gets Up To 44 Percent Performance Bump

Here’s Our Favorite Cosplay From Dragon Con 2024

Nordstrom’s Early Black Friday Sale is live! Save up to 60% off Nike, Cole Haan, On Cloud, more

Latest Bose Ultra Open earbuds with spatialized audio return to $249 Amazon low

News

Drug makers can’t make knockoff weight-loss drugs anymore—and they’re mad

ArsTechnica.com - 0
Compounding pharmacies could make knockoffs during shortage. But FDA says it's over.
Read more
News

Eli Lilly raises price of Zepbound while trumpeting discount on starter vials

ArsTechnica.com - 0
Cost for insured patients without coverage for the drug rises from $550 to $650 a month.
Read more
News

Man suffers heart problem after rapid weight loss: A GLP-1 cautionary tale

ArsTechnica.com - 0
The man developed atrial fibrillation and required hospitalization.
Read more
News

People are overdosing on off-brand weight-loss drugs, FDA warns

ArsTechnica.com - 0
Bad math and unclear directions are behind overdoses of up to 20 times the normal amount.
Read more
News

28 Million Obese Patients Are Expected To Be On GLP-1 Drugs By 2029

Wccftech.com - 0
In what substantially bolsters the veracity of the tagline that the GLP-1 anti-obesity drugs constitute one of the most compelling cases of thematic investing this decade, UBS is out today with a fresh investment note that illustrates the scale of this ongoing paradigm shift in how the healthcare industry deals with the persistent obesity pandemic. The GLP-1 hormone suppresses hunger and regulates the production of insulin and glucose. After a meal, this hormone raises the level of insulin, which decreases blood glucose levels, and reduces the rate at which the stomach empties its contents into the small intestine, creating a […]
Read more
News

Pharma Hunger Games: Eli Lilly And Company’s GLP-1 Weight Loss Drug Is Much More Effective Than Novo Nordisk’s Says A New Study

Wccftech.com - 0
With potentially $100 billion in annual sales by 2030 up for grabs, the competition in the GLP-1 weight loss drugs space is predictably heating up, with Eli Lilly and Company (LLY) going head-to-head with the European pharma giant Novo Nordisk (NVO). A new study has upended the perceived parity between these two pharma heavy-weights, however, with Eli Lilly and Company managing to score a direct hit against Novo Nordisk. JAMA Study: Use Of Eli Lilly And Company's GLP-1 Agonist Tirzepatide Was Associated With Significantly Greater Weight Loss Than Novo Nordisk's Semaglutide For the benefit of those who might not be […]
Read more
News

New weight-loss and diabetes drugs linked to lower risk of 10 cancers

ArsTechnica.com - 0
For diabetes patients, GLP-1 drugs linked to lower cancer risks compared to insulin.
Read more
News

The GLP-1 Agonist Found In Wegovy And Ozempic Drugs Might Help In Controlling Alcohol Addiction, As Per A New Study

Wccftech.com - 0
From offering a viable solution to the obesity pandemic and its comorbidities to reducing the demand for ResMed's continuous Positive Airway Pressure (PAP) therapy devices that are used to treat the symptoms of sleep apnea, it is hardly surprising that GLP-1 drugs currently constitute one of Wall Street's biggest thematic investment ideas for the ongoing decade. Even so, researchers continue to discover new use-cases for these miracle drugs, with the latest such discovery centering on alcohol addiction control. A Primer On GLP-1 Drugs The GLP-1 hormone suppresses hunger and regulates the production of insulin and glucose. After a meal, this […]
Read more
News

Around 42 Percent Of Those Aged 20 And Above In The US Are Obese, Yet GLP-1 Weight Loss Drugs Are Not Covered By 99...

Wccftech.com - 0
Wall Street is convinced that anti-obesity GLP-1 drugs constitute a thematic bull case, with Goldman Sachs recently pegging its estimate of annual global sales of these drugs at $130 billion by 2030. In fact, financial analysts have already begun to downgrade the long-term demand outlook for fast food giants such as McDonald's, based on assumptions that 7 percent of the total population in the US would be using GLP-1 drugs in the next 10 years, with the average caloric consumption of those users declining by around 20 percent. Yet, it is the exorbitant price tags of these drugs - at […]
Read more
News

Some Analysts Do Not Want You To Write Off Madrigal In Favor Of Eli Lilly And Company’s GLP-1 Agonist For The Treatment Of Fatty...

Wccftech.com - 0
Eli Lilly and Company (NYSE: LLY) is currently one of the two primary darlings of Wall Street when it comes to thematic investing around anti-obesity GLP-1 drugs, with Novo Nordisk constituting the other end of this emerging duopoly. Yet, it is the precise heft of these two pharma giants that continues to present emergent opportunities to their smaller counterparts, especially in obesity-related diseases such as the Metabolic dysfunction-Associated Steatohepatitis (MASH, previously known as Nonalcoholic Ateatohepatitis or NASH). For the benefit of those who might not be aware, MASH is a fatty liver disease that develops primarily due to metabolic disorders, including […]
Read more
News

The next food marketing blitz is aimed at people on new weight-loss drugs

ArsTechnica.com - 0
Taking a weight-loss drug? Food makers have just the new food for you.
Read more
News

“Outrageously” priced weight-loss drugs could bankrupt US health care

ArsTechnica.com - 0
Prices would need to be dramatically slashed to avoid increasing the national deficit.
Read more

Tag: GLP-1

How To Unlock Every Hero And Weapon Evolution In Vampire Survivors Ode To Castlevania DLC

gaming
Vampire Survivors draws tons of inspiration from Castlevania, so it is no surprise that the new Ode To Castlevania DLC is fantastic. I’m here to guide you through unlocking each Hero and evolving each weapon, because that’s how you’ll end up accessing ...

Overwatch Players, Y’all Lived Like This In 2016?

gaming
I started playing Overwatch in 2019. By the time I was pushing payloads and getting Play of the Game with a well-placed Tactical Visor, a lot of the old hero kits and team compositions that were infamous when the hero shooter launched in 2016 were more...

Drug makers can’t make knockoff weight-loss drugs anymore—and they’re mad

News
Compounding pharmacies could make knockoffs during shortage. But FDA says it's over.

Eli Lilly raises price of Zepbound while trumpeting discount on starter vials

News
Cost for insured patients without coverage for the drug rises from $550 to $650 a month.

Man suffers heart problem after rapid weight loss: A GLP-1 cautionary tale

News
The man developed atrial fibrillation and required hospitalization.

People are overdosing on off-brand weight-loss drugs, FDA warns

News
Bad math and unclear directions are behind overdoses of up to 20 times the normal amount.

28 Million Obese Patients Are Expected To Be On GLP-1 Drugs By 2029

News
In what substantially bolsters the veracity of the tagline that the GLP-1 anti-obesity drugs constitute one of the most compelling cases of thematic investing this decade, UBS is out today with a fresh investment note that illustrates the scale of this ongoing paradigm shift in how the healthcare industry deals with the persistent obesity pandemic. The GLP-1 hormone suppresses hunger and regulates the production of insulin and glucose. After a meal, this hormone raises the level of insulin, which decreases blood glucose levels, and reduces the rate at which the stomach empties its contents into the small intestine, creating a […]

Pharma Hunger Games: Eli Lilly And Company’s GLP-1 Weight Loss Drug Is Much More Effective Than Novo Nordisk’s Says A New Study

News
With potentially $100 billion in annual sales by 2030 up for grabs, the competition in the GLP-1 weight loss drugs space is predictably heating up, with Eli Lilly and Company (LLY) going head-to-head with the European pharma giant Novo Nordisk (NVO). A new study has upended the perceived parity between these two pharma heavy-weights, however, with Eli Lilly and Company managing to score a direct hit against Novo Nordisk. JAMA Study: Use Of Eli Lilly And Company's GLP-1 Agonist Tirzepatide Was Associated With Significantly Greater Weight Loss Than Novo Nordisk's Semaglutide For the benefit of those who might not be […]

New weight-loss and diabetes drugs linked to lower risk of 10 cancers

News
For diabetes patients, GLP-1 drugs linked to lower cancer risks compared to insulin.

The GLP-1 Agonist Found In Wegovy And Ozempic Drugs Might Help In Controlling Alcohol Addiction, As Per A New Study

News
From offering a viable solution to the obesity pandemic and its comorbidities to reducing the demand for ResMed's continuous Positive Airway Pressure (PAP) therapy devices that are used to treat the symptoms of sleep apnea, it is hardly surprising that GLP-1 drugs currently constitute one of Wall Street's biggest thematic investment ideas for the ongoing decade. Even so, researchers continue to discover new use-cases for these miracle drugs, with the latest such discovery centering on alcohol addiction control. A Primer On GLP-1 Drugs The GLP-1 hormone suppresses hunger and regulates the production of insulin and glucose. After a meal, this […]

Around 42 Percent Of Those Aged 20 And Above In The US Are Obese, Yet GLP-1 Weight Loss Drugs Are Not Covered By 99...

News
Wall Street is convinced that anti-obesity GLP-1 drugs constitute a thematic bull case, with Goldman Sachs recently pegging its estimate of annual global sales of these drugs at $130 billion by 2030. In fact, financial analysts have already begun to downgrade the long-term demand outlook for fast food giants such as McDonald's, based on assumptions that 7 percent of the total population in the US would be using GLP-1 drugs in the next 10 years, with the average caloric consumption of those users declining by around 20 percent. Yet, it is the exorbitant price tags of these drugs - at […]

Some Analysts Do Not Want You To Write Off Madrigal In Favor Of Eli Lilly And Company’s GLP-1 Agonist For The Treatment Of Fatty...

News
Eli Lilly and Company (NYSE: LLY) is currently one of the two primary darlings of Wall Street when it comes to thematic investing around anti-obesity GLP-1 drugs, with Novo Nordisk constituting the other end of this emerging duopoly. Yet, it is the precise heft of these two pharma giants that continues to present emergent opportunities to their smaller counterparts, especially in obesity-related diseases such as the Metabolic dysfunction-Associated Steatohepatitis (MASH, previously known as Nonalcoholic Ateatohepatitis or NASH). For the benefit of those who might not be aware, MASH is a fatty liver disease that develops primarily due to metabolic disorders, including […]

The next food marketing blitz is aimed at people on new weight-loss drugs

News
Taking a weight-loss drug? Food makers have just the new food for you.

“Outrageously” priced weight-loss drugs could bankrupt US health care

News
Prices would need to be dramatically slashed to avoid increasing the national deficit.
123Page 1 of 3

Recent articles

spot_img

©Patti.tech 2022